明德生物：8月27日召开董事会会议

Group 1 - The company Mindray Bio-Medical Electronics announced the convening of its 21st meeting of the 4th board of directors on August 27, 2025, to review the special report on the use of raised funds for the first half of 2025 [1] - The meeting included discussions on the status of fundraising and its application, indicating ongoing financial management and strategic planning [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into a human, raising questions about the timeline for clinical applications [1] - This breakthrough could have implications for the biotechnology and healthcare industries, particularly in organ transplantation and genetic research [1]